Consequently, this upregulation hinders the expression of DNMT1 protein and its interaction with the promoter region of KLF4, resulting in a decrease in promoter DNA methylation and the activation of KLF4 expression within pancreatic cancer cells. The gene discussed is DNMT1; the disease is familial pancreatic carcinoma.